Compare MERC & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MERC | XTNT |
|---|---|---|
| Founded | 1968 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Paper | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.5M | 88.7M |
| IPO Year | 2005 | 2009 |
| Metric | MERC | XTNT |
|---|---|---|
| Price | $1.26 | $0.58 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $2.50 | $1.50 |
| AVG Volume (30 Days) | ★ 374.2K | 99.1K |
| Earning Date | 04-30-2026 | 03-06-2026 |
| Dividend Yield | ★ 11.54% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | ★ $1,169,145,000.00 | $53,337,000.00 |
| Revenue This Year | $13.75 | $15.08 |
| Revenue Next Year | $10.12 | N/A |
| P/E Ratio | ★ N/A | $19.34 |
| Revenue Growth | ★ 25.50 | N/A |
| 52 Week Low | $1.27 | $0.34 |
| 52 Week High | $6.78 | $0.95 |
| Indicator | MERC | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 22.96 | 47.83 |
| Support Level | N/A | $0.55 |
| Resistance Level | $2.30 | $0.68 |
| Average True Range (ATR) | 0.10 | 0.05 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 4.31 | 26.21 |
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.